Vorinostat

Vorinostat is a medication used primarily to treat certain types of cancer, specifically cutaneous T-cell lymphoma, a condition affecting skin cells. It works by inhibiting enzymes called HDACs (histone deacetylases), which play a role in modifying how genes are expressed. By blocking these enzymes, Vorinostat helps to reactivate tumor-suppressing genes and leads to cancer cell death. It is taken as a pill and has been studied for its potential use in other cancers as well. Like all medications, it can have side effects, and its use is supervised by healthcare professionals.